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Rapid and accurate detection of a blood stream infection is critical for the proper 
management of patients displaying symptoms of sepsis. Current blood culture systems are 
both time consuming and may yield low recovery in the presence of antibiotics, delaying 
needed results for effective sepsis management. To improve recovery rates and time to 
detection, a novel sample preparation and culture device system was created. The design 
concentrates the microorganisms into a small volume, while removing antibiotics and 
inhibitory blood components. This system allows for both increased recovery and decreased 
time to detection, granting rapid and accurate detection of blood stream infections to help 
clinicians diagnose septicemia.  
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Sepsis is considered among the most significant healthcare issues due to high 
incidence and high mortality rate.1 The mortality rate is especially concerning, as sepsis 
contributes to 33-55 percent of all hospital deaths, while occurring in 10 percent of all 
hospital patients.2 Furthering its case as a leading public health concern, sepsis accounted for 
over $20 billion (5.2%) of US hospital costs in 2011.3 
Although sepsis can affect anyone, certain groups are at an increased risk. Those with 
other health problems, such as diabetes, and those who have recently been hospitalized or 
had an invasive medical procedure are particularly vulnerable. Also at greater risk are those 
with compromised immune systems, such as patients with HIV or cancer, very young babies, 
and the elderly.4 These risk factors stem from the limited ability to fight infection, increasing 
the chances that an infection progresses to sepsis in these patient populations. 
Sepsis, a clinical syndrome characterized by a dysregulated host response to 
infection, often leads to organ failure and ultimately death.5 This dysregulated response may 
arise due to the presence of an infectious microorganism in numerous bodily tissues, 
although blood stream infections are among the most common causes. Sepsis is considered 
severe when signs of organ dysfunction or altered cerebral function appear. If blood pressure 
drops to dangerous levels, the diagnosis of septic shock is then made.1 The infection causing 
sepsis is usually associated with illness, but can also arise from an injury or follow a routine 
surgery. 
If a doctor suspects sepsis, a number of tests will be run to diagnose the condition. 
These tests look for a number of markers including, a high or low white blood cell count, a 
low platelet count, acidosis, altered organ function, and infectious microorganisms within 
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bodily fluids.6 While cell counts and altered organ function can help lead to a sepsis 
diagnosis and general treatment to keep vital organs functioning, isolating bacteria from the 
infection source is necessary to determine antibiotic susceptibility. Determining to which 
antibiotics a particular infection is most susceptible allows clinicians to employ the most 
effective treatment to fight the infectious microorganism.7 
The current process for determining antibiotic susceptibility begins by taking a blood 
sample from the patient for blood culture. Blood culture involves the collection, incubation, 
growth, and detection of viable microorganisms within a blood sample. Following the 
culture, the microorganism must be isolated and then have identification and antibiotic 
susceptibility testing performed. This process can be exceedingly time-consuming, thus 
delaying the time before optimal treatment. Figure 1, below, shows a sample timeline from 
collection to the needed antibiotic susceptibility result. 
 
Figure 1. Timeline of traditional blood culture from collection/transport to identification (ID) 
and antibiotic susceptibility testing (AST). 
 
The most widely used systems for blood culture are BACTEC (Becton Dickinson) 
and BacT/Alert (bioMerieux). Each system uses its own proprietary media, detection system, 
and algorithms. However, both follow a similar protocol: A roughly 10-mL blood sample is 
taken from a patient and inoculated into a bottle containing growth media; the sample is 
transported to a lab and placed into a machine that incubates the sample and employs 
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continuous monitoring to alert when microbial growth has been detected. After a positive 
result, the bacteria/fungi must be isolated to allow for downstream processing steps leading 
to identification and antimicrobial susceptibility testing. Although the specifics of 
identification and antimicrobial susceptibility testing are beyond the scope of this work, this 
isolation step is extremely relevant since it arises due to the nature of current systems and can 
add upwards of 24 hours before antimicrobial susceptibility testing can be performed. 
Current automated blood culture systems, such as the BACTEC and BacT/Alert, have 
an extremely simple workflow and minimal risk for contamination. This is due to the closed 
nature of these systems. Since a sample is collected and inoculated directly into a sealed 
bottle, nearly all contaminants originate from the patient’s skin. This allows minimization of 
contamination via sterilization of the draw site, and also allows clinicians to generally 
recognize coagulase-negative staphylococci as potential contaminants.8 In addition; these 
systems provide high recovery in the absence of antibiotics. In the simplest sense, high 
recovery means that the bacteria present in a patient’s blood are captured in a viable state and 
grow until detection. These systems yield high recovery because there is almost no area for a 
loss of viable organisms; the blood is transferred directly to a culture bottle, and then viable 
organisms should be sustained within the growth media. However, when antibiotics are 
present recovery is often decreased, since the inactivation of antibiotic by charcoal or resin is 
time dependent, many previously viable organisms may be lost before the antibiotics are 
effectively neutralized. 
These systems for growing and detecting microorganisms have been used for decades 
and while they have many positives, there are certainly drawbacks to such systems. Chief 
among them is the amount of time it takes to obtain a result. The time to determine the 
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presence of a microorganism can take 12 – 72 hours depending on the organism and whether 
or not the patient is on an antibiotic regimen. Further, antibiotics can significantly reduce 
recovery, even in systems using activated charcoal or resins to neutralize antibiotics.  
Some aspects of these problems are inherent of the nature of current blood culture 
systems. A relatively large volume of blood (~10 mL) is needed to ensure viable organisms 
are captured, and then once growth media is added, the increased total volume significantly 
reduces the initial bacterial concentration. Since the starting concentration is dilute, it takes 
more time for a sample to reach a sufficiently high concentration and to be detected. A 
simple blood culture bottle may contain resins to effectively neutralize some antibiotics; 
however, these systems do not effectively eliminate all antibiotics from the microorganism 
environment, which inevitably leads to a decrease in susceptible cell viability. Further, these 
systems culture the pathogenic organism within a mixture of growth media and the patient’s 
whole blood. The presence of the various blood components can inhibit the growth rate of 
some organisms, but more importantly, downstream processing, such as antimicrobial 
susceptibility testing, require pure organisms free from blood components. Currently, to 
acquire pure organisms from a positive blood culture bottle, a subculture is taken from the 
bottle, inoculated on plated media and allowed to grow. This extra step can add more than 24 
hours between a positive test result and knowing how to effectively treat the infection. 
The mechanism of detection of aerobic microorganisms in the BACTEC automated 
blood culture system is based on CO2 sensing. Microorganisms undergoing aerobic 
respiration use oxygen to produce ATP. Proteins and sugars are often consumed as reactants, 
while CO2 is generated as a product of the reaction. Although this is a simplified view of 
respiration, it is the basis for the CO2 detection mechanism within BACTEC systems. As a 
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sensor within the system indirectly detects the amount of CO2 present at a given time, an 
algorithm analyzes the data, combines this data with previous time-points, and determines 
whether there is growth occurring within the culture bottle. This process is similar for other 
automated culture systems, such as BacT/Alert, although the method in which CO2 is 





One specific aim of this project is to create a bacterial enrichment system, which 
serves to increase the recovery of viable microorganisms, from the point of sample collection 
through growth and detection. Current blood culture methods yield high recovery in the 
absence of antibiotics; however, many patients have antibiotics administered before a blood 
culture specimen is taken. The proposed system must mitigate the effect that antibiotics 
present in the patient’s bloodstream may have on the viability of susceptible organisms 
within the culture device. 
Another specific aim is for this system to enable a decrease in total time before an 
antimicrobial susceptibility result is obtained. Current blood culture systems can take from 
12-72 hours to determine the presence of a pathogen. After the presence of a pathogen is 
confirmed, it can take up to another 24 hours to prepare the specimen for identification and 
antimicrobial susceptibility testing. Since, over the first six hours following hypotension 
onset, there is a ~7% increase in mortality for every hour before effective antimicrobial 







 To achieve the two specific aims of this project, it is necessary to design a system 
from the point of sample collection through sample preparation for identification and 
antimicrobial susceptibility testing. This is achieved by modifying the steps of traditional 
blood culture, shown above in Figure 1. Figure 2, below, showcases the modified steps. 
 
Figure 2. Modified blood culture steps for increasing recovery and decreasing time-to-
detection (TTD). 
 
These modified steps allow for a number of improvements over the traditional blood 
culture method. The introduction of a selective lysis step will improve recovery by freeing 
any viable microorganisms that are engulfed by white blood cells. Meanwhile, the filtration 
step will enable the complete removal of antibiotics AND inhibitory blood components, 
while also concentrating the microorganisms into a small volume. Further, filtering and 
concentrating the samples allows for reconstitution in a small volume of pure media, 
simplifying downstream processing. Since only ~10% of infections are mixed10,11 i.e. contain 
more than one pathogenic microorganism, in roughly 90% of cases filtration will allow the 
bacteria to grow in a pure culture, enabling the complete removal of an up to 24-hour 




 In order to increase viable organism recovery, antibiotics must be neutralized, 
whether through chemical or physical means. This project approaches this challenge by using 
direct physical separation, via filtration, to remove antibiotics from the environment of the 
microorganism of interest. By using a filter with a pore size small enough to retain all 
potentially infectious microorganisms, and large enough to allow antimicrobials within the 
sample to pass, it is possible to completely eliminate antibiotics from the environment around 
the infectious microorganism. Further, this method also eliminates blood components, such 
as complement, which may inhibit microbial growth. 
 While this method removes inhibitory factors and antibiotics from the sample, it also 
removes blood factors, such as Component A and Component B, which are essential for 
some organisms.12 This will reduce recovery of a small subset of organisms and thus the 
grow media must be supplemented with the necessary factors. 
 
Time to Detection (TTD) 
 In order to decrease the time to detect the presence of an infectious microorganism, a 
few approaches may be taken. One method is to concentrate the microorganisms in a reduced 
volume. Microorganisms can be concentrated in a reduced volume by filtering the initial 
sample, and then adding a small volume of growth media to the microorganisms trapped on 
the filter. Traditional blood culture has a total volume of around 40 mL, whereas filtering and 
then adding growth media allows for volumes <1 mL. This 40-fold volume decrease equates 
to ~5.3 doublings (i.e. 25.3 ≈ 40), meaning that this volume reduction alone can reduce the 
time to detection by 5.3 generations. This saves about 2 hours for fast growing organisms 
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such as E. coli (~23 min/gen), however, the effect is much more significant for slow growing 
organisms such as C. albicans (~73 min/gen), saving roughly 6.5 hours. 
Another method to decrease TTD is by employing a more sensitive detection 
mechanism. An indirect CO2 sensor is the standard detection mechanism; however, by 
removing blood components from the microbial environment, it becomes possible to explore 
other chemical and physical detection methods. Two detection mechanisms; one chemical: 
resazurin, and one physical: turbidity; are chosen to be compared to traditional CO2 sensing. 
Resazurin is a weakly fluorescent blue dye, which is reduced to the red, highly 
fluorescent, resorufin. As cells proliferate in the presence of resazurin, it is chemically 
reduced and can be detected using a fluorescence detector. Resazurin was chosen since the 
cells must remain fully functional for downstream testing and other assays, such as MTT, can 
impact the electron transport chain leading to cell death. 
 Turbidity is the cloudiness of a fluid caused by a large number of individual particles 
in suspension. A nephelometer, which employs a source beam and a detector 90 of the 
source beam, grants a relative measure of the turbidity of a solution. The signal received by 
the detector is a function of the particle density, as well as the shape, color, and reflectivity of 
the particles. As the cells propagate the particle density of the growth media solution 




The above approaches for improving recovery and TTD both rely on one important 
factor: isolating microorganisms from a sample of whole blood. Common methods to attempt 
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this include centrifugation, filtration, and surface capture/antibody techniques. Generally, 
surface capture techniques do not work with a broad spectrum of organisms, while 
centrifugation-based methods rely on more complicated processing steps. Therefore, a 
filtration-based method is pursued, since it allows for a simple disposable device, needing 
only a source of vacuum to supply the force for separation.  
Filterability of a 10-mL sample of whole blood depends on a number of factors. Some 
of these factors can be designed and controlled, such as the lysis and digestion methods, and 
filter membrane properties. Other factors, such as patient blood composition (white cell 
count, medications, clotting factors, etc.) cannot be controlled. Further, microorganisms must 
remain viable during transport to the lab for filtration. 
A pre-developed media is used as the basis of a transport media, while filter 
membrane materials and coatings must be investigated to maximize filterability. Since 
transport time to the lab can vary greatly among hospitals, it will be important to test how 





System Development and Testing 
Overview 
 The approach to developing this system can be broken down into a few key 
components. The first component is a media capable of lysing blood cells, while sustaining 
the viability of the microorganisms of interest. This media must also maintain microorganism 
viability in the presence of antibiotics during the period of transport between collection from 
the patient and filtration in the lab. Once in the lab, the media must allow for filtration of the 
entire volume of collected sample. 
The next component for this system is filtration geometry. Filtration was initially 
carried out using a commercially available preassembled vertical filter with a proprietary 
peristaltic pump. However, a preassembled filter with proprietary pump connections offers 
little flexibility, so the geometry and adaptability of different filter holders was evaluated. 
While the geometry and customizability of the filter holder was considered, the critical aspect 
of the filtration setup is the filter membrane. Filterability while using a number of 
commercially available membrane materials was evaluated.  
Once the sample has been filtered, it is necessary for the organisms to grow in order 
to be detected, so it is necessary to develop a nutrient rich growth media that supports all of 
the clinically significant organisms. A commercially available media is the basis of the 
growth media formulation, although additions are necessary to ensure certain fastidious 
organisms are capable of growth. As the organisms within a sample grow, it is important to 
have a sensitive detection system in order to minimize TTD. The current standard for 
detection is indirect CO2 detection, which means the developed system should show 
12 
  
sensitivity greater than this standard. The sensitivities of two other detection systems are 
compared to indirect CO2 detection.  
 
Transport Media 
 The first piece of this approach is a transport media capable of allowing selective 
lysis of the blood cells, while preserving viable microorganisms. This media is based on a 
commercially available growth media; however, the purpose of this media is to simply allow 
transport, so the nutrients were reduced to the minimum required for viability. This reduction 
in nutrients is necessary since the mechanism of certain antibiotics, such as Antibiotic E, 
inhibits the cell wall synthesis of replicating bacteria. Supplying minimal nutrients to the 
organism will cause it to replicate more slowly, thus making it less susceptible to this type of 
antibiotic.  
 Component C was added to the transport media not only to serve as an anticoagulant, 
but also to inactivate Class A antibiotics. Table 1, below, shows the viability of 
Pseudomonas aeruginosa when it is exposed to peak serum levels of Antibiotic A, a common 
Class A antibiotic, within the transport media containing varying concentrations of 
Component C.  





Fraction viable cells 
remaining after  
4 hours of incubation 

























 The above table shows that Concentration 3 of Component C is required to protect P. 
aeruginosa from Antibiotic A within the base transport media. This is near the cutoff of 
where Component C concentration begins to affect filterability. Filterability was measured by 
following Protocol 1, in the Appendix, and having a transport time of 0. As seen in Table 2, 
below, filterability is severely impacted at higher Component C concentrations. Table 2, in 
conjunction with Table 1, show that an acceptable Component C concentration to afford 
protection from Antibiotic A and allow filtration is around Concentration 3. 
Table 2. Filterability of fresh blood in transport media containing 
varying Component C levels 
 
Component C Concentration 
Level 
Filtration time 
3 Component C Failed 
3 Component C Failed 
2 Component C 47 sec 
1 Component C 32 sec 
No Component C 33 sec 
 
 Another additive to the transport media is Component D. Component D has been 
shown to increase the degradation of Class B antibiotics, such as Antibiotic B. The effect of 
Component D on Antibiotic B is shown below, in Table 3. The effect of Component D on 
Antibiotic B can also be showcased chemically as seen in Figure 3. This data shows that 





Table 3. Cell viability with Component D and Antibiotic B. 
Condition 
Relative Cell Viability (%) 
After 4h Incubation 
No Component D 
No Antibiotic B 
395% 
Peak Serum Antibiotic B 22% 
0.8% Component D 469% 
0.8% Component D 




Figure 3. Chemical reduction of Antibiotic B by Component D, measured by absorbance 
(λ=520nm). 
 
Following blood cell lysis, a protease is added to digest proteins within the blood 
serum and those released from lysed cells. This step is somewhat delicate, since the protease 
can also render the microorganism of interest nonviable. Since the protease activity is 
impacted by the temperature, incubation at a fixed temperature for a fixed time was selected 
to maximize both microorganism viability and sample filterability. 
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Once an initial transport media containing detergents for lysis, Component C for 
anticoagulation and Class A antibiotic protection, buffer, and minimal nutrients was shown to 
be capable of maintaining organism viability through protease digestion, testing was 
performed to quantify the impact of transport time. After a sample is collected from a patient, 
it could sit in the transport media for hours before it reaches the lab and protease digestion 
can be initiated. It is important to ensure that the organisms of interest remain viable and the 
sample remains filterable over this transport window. This media composition was tested to 
quantify the filterability of blood samples across a range of potential transport times. Testing 
was carried out by following Protocol 1, contained in the Appendix. Figure 4, below, shows 
filtration times for varying “transport time”, Component C concentration, and blood donor. 
“Saline” indicates transport media containing nothing but detergents and minimal 
Component C. It is used as a control to show the filterability when no nutrients, buffers, or 




Figure 4. Filterability following transport of 0, 2, and 4 hours (n=9).  
 
Samples must not only remain filterable, but must also maintain viable 
microorganisms. To determine viable organism recovery, different antibiotic-susceptible 
microorganism combinations were tested. To test this, transport media bottles were spiked 
with peak serum concentrations of certain antibiotics, and known quantities of susceptible 
bacteria, following Protocol 2, in the Appendix. The results, Figure 5, show that in the 
presence of certain antibiotics, viability is maintained and some organisms even begin to 
grow quite rapidly. However, certain drug-bacteria combinations are problematic, namely E. 





Figure 5. Microorganism growth within transport media in presence of antibiotics. Tested 
across two donors. 
 
Filtration Geometry 
To maintain simplicity within the device, dead-end filtration was chosen over other 
filtration techniques, such as tangential flow. However, there are still numerous geometries 
that can be implemented. The two geometries considered are shown in Figure 6. 
 
Figure 6. Different filter geometries. A) disk filter holder B) off-the-shelf vertical filter 
 
Figure 6A shows a simple disc filter, where a pressure differential is created by 
applying a vacuum in the middle of one side of the filter and introducing a feed to the middle 




pressure differential is created by applying a vacuum at the top (back side) of the filter and 
introducing the sample at the bottom (front side) of the filter. This still involves the creation 
of a pressure differential across the membrane, but the vertical offset between the inlet and 
outlet creates a pressure drop down the backside of the filter as the membrane begins to foul. 
This can lead to residual material on the bottom backside of the filter that cannot be washed 
away. 
 
Filter Membrane Material Selection 
Once filtration geometry is selected, a membrane type must be chosen to enclose 
within the device. A number of different membrane materials are commonly used for 
biological filtration. These membrane materials include: polyethersfulfone (PES), 
polyvinylidene difluoride (PVDF), cellulose acetate (CA), and track-etched polycarbonate 
(PCTE). The chosen CA, PES, and PVDF membranes are all compromised of fibrous 
meshes, whereas the PCTE membrane consists of a relatively smooth surface that has 
cylindrical pores etched through it. Further, the supplied CA, PES, and PVDF membranes 
were all hydrophilic, compared to the PCTE membranes, which were available with a 
hydrophilic polyvinylpyrrolidone (PVP) coating, or in an uncoated state. Although the 
uncoated PCTE has a water contact angle slightly below 90o, which is moderately 
hydrophobic, it is referred to as hydrophobic in order to differentiate the property difference 
between the coated and uncoated PCTE membranes. A pore size of 0.45 µm was chosen for 
the fibrous membranes, while a pore size of 0.40 µm was available for the track-etched 
membrane. Although 0.22 µm has become the standard for sterile filtration, the pathogenic 
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organisms of interest are all greater than 0.40 µm, and the larger pore size allows for easier 
filtration. 
 To quickly screen the above membranes, an experiment was designed to test the 
filterability of lysed and digested blood across each membrane using an effective filtration 
area of 13.2 cm2. This area is much larger than the desired area within a consumable (~3–5 
cm2), so if a membrane struggles to filter at this surface area, it can be ruled out as a potential 
component of the final system. 
 For each sample, 10 mL of fresh blood was collected and processed according to 
Protocol 3, contained in the Appendix. A high vacuum pressure (-0.85 bar) was used, since 
any materials that fail at high pressure and high surface area will not suffice at the lower 
surface area, as desired in the final device. Table 4, below, shows the initial screening results 
of this experiment for 2 samples each of CA, PES, PVDF, hydrophilic and hydrophobic 
PCTE, and a control filter of the previous geometry. These initial results make it clear that 
the CA and PES filter membranes from this particular supplier do not work in this 
application. 





Vacuum Pressure  
(bar) 
Average Filtration Time  
(sec) 
CA 0.85 DNF 
PES 0.85 DNF 
PVDF 0.85 16±9 
PCTE (hydrophobic) 0.85 8±4 
PCTE (hydrophilic) 0.85 15±8 




The vacuum pressure was varied and the above experiment repeated for PVDF, 
hydrophilic PCTE, and hydrophobic PCTE. It is important to note that fresh blood samples 
were obtained from multiple donors and each membrane was tested with each donor. Since 
the properties of the blood from an individual donor impact filtration, it is important to 
control this during measurements. For a given donor, hydrophobic PCTE filtered over twice 
as quickly as the PVDF, while hydrophilic PCTE outperformed PVDF by an insignificant 
amount. The below plot, Figure 7, shows a comparison between the hydrophilic and 
hydrophobic PCTE. As shown in the plot, the hydrophobic membrane performs nearly twice 
as well at any given pressure. Also of note, the hydrophilic membrane experienced filtration 
failures at pressures as high as 0.60 bar, whereas the first failure for the hydrophobic 
membrane was at 0.40 bar. 
Figure 7. Filtration time for PCTE with hydrophobic and hydrophilic coating. 
Note: Filtration time was capped at 210 seconds, meaning any sample that reached 210 




 To further confirm the choice of hydrophobic PCTE as the filter membrane material, 
a 2-sample t-test was performed. This showed that at high pressures (> 0.60 bar) the 
difference between the mean filtration time using PCTE hydrophobic and PCTE hydrophilic 
membranes was statistically significant (p-value = 0.016). The variance between the two 
membrane materials was also compared. Figure 8 shows the results of this comparison and 
makes it clear that the hydrophobic membranes not only allow for faster filtration, but allow 
for more consistent filtration times. Consistent filtration times imply that the hydrophobic 
membrane is better suited to handle a broad spectrum of patient blood samples, since the 
hydrophobic membrane did not experience the effects of “difficult” donors as harshly as the 
hydrophilic membranes. 
 























Test for Equal Variances: Filtration Time vs Material
Multiple comparison intervals for the standard deviation, α = 0.05
If intervals do not overlap, the corresponding stdevs are significantly different.
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Once the hydrophobic PCTE membrane was decided upon, more filtration tests were 
conducted using a much smaller surface area. Protocol 4 describes the process used to 
prepare and filter samples on a filter holder with an effective surface area of 3.5 cm2. Figure 
9 shows filterability results for these filters containing hydrophobic PCTE membranes. As 
seen in Figure 9, filterability is maintained with the lower surface area, and the average 
filtration time is roughly 1 minute. 
 
Figure 9. Filtration flow rates across 9 donors for 25-mm PCTE hydrophobic membranes. 
Note: Samples were 22 mL, so filtration time = 22 mL / flow rate. 
 
To further characterize the fouling during filtration, SEM images were taken of the 25 
mm filter membranes in different conditions. Figure 10, contains images of the membrane 
pores, both with and without debris from blood filtration. This figure also showcases the 




Figure 10.  SEM images of hydrophobic PCTE filter A) surface containing debris B) freeze 





 After antibiotics and blood components are removed from a sample, there are 
numerous ways to detect whether or not growth occurs. The traditional method of detection 
used in automated blood culture systems, such as BACTEC, incorporate an indirect CO2 
sensor. This sensor indirectly measures the change in CO2 within the sample vial and once 
the rate of CO2 production increases to a certain point, the sample is signaled as positive. The 
rate of CO2 production is indicative of growth because as aerobic organisms respirate, they 
convert O2 into CO2.  
 A simple experiment was performed to estimate the detection sensitivity of a 
BACTEC system. A known concentration of E. coli was spiked into a BACTEC bottle 





detection occurred. Once the bottle was considered positive by the BACTEC, it was removed 
and the final E. coli concentration calculated by creating serial dilutions and inoculating BD 
TSA II 5% Sheep Blood plates with the sample. The growth curve generated by the 
instrument is shown below in Figure 11, which indicates the values of the starting 
concentration and most importantly the concentration at detection. The concentration at 
detection of 2.1  108 CFU/mL indicates that for bacteria that replicate and produce CO2 at a 
similar rate to E. coli, detection will occur at a concentration on the order of 108 CFU/mL. 
The detection time is based on algorithms, applied to the data by the BACTEC 
software, in order to indicate growth. In general, such algorithms are based on an 
acceleration of the signal, which is indicative of exponential growth. The concept of signal 
acceleration as a sign of exponential growth is applied in the following experiments in order 
to estimate positivity for setups, which do not contain tuned algorithms like the BACTEC. 





Figure 11. BACTEC generated growth curve of E. coli.  
 
A potentially alternative method of detection is using a resazurin indicator. As the 
microorganisms proliferate in the presence of the indicator, resazurin is chemically reduced 
to resorufin. In its reduced state this indicator can be detected via fluorescence measurement. 
An experiment similar to the one performed on the BACTEC was performed using 
the resazurin indicator and a fluorescence detector. A known concentration of E. coli was 
spiked into growth media containing indicator and placed into an incubator adapted to 
contain a fluorescence detector. The change in fluorescence was monitored and a detection 
time was estimated based on the curve. This data is represented below, in Figure 12. Since, 
this system does not have developed real-time detection algorithms, the samples were 
Starting concentration 5  104 CFU/mL 




removed roughly 15 minutes after the positivity point. Since E. coli has a generation time of 
a little more than 20 minutes, it can be estimated that the final concentration of 2.1  108 
CFU/mL is no more than twice the actual concentration at positivity. This means that the 
sensitivity of resazurin-based detection is on the same order of magnitude as the BACTEC 
CO2 mechanism (~10
8 CFU/mL).  
 
Figure 12. Growth curves of E. coli using resazurin detection. 
 
The other detection method evaluated was nephelometry. A nephelometer employs a 
source beam and detector 90 degrees of the beam to grant a relative measure of the turbidity 
of a solution based on light scattering intensity. Meaning that as more particles are present in 
a suspension, more light is scattered leading to a higher output voltage. This does not rely on 
acceleration metrics like CO2 production or resazurin reduction, so it is possible to simply 
add a known concentration of organism in growth media to a cuvette and place within a 
nephelometer to get an estimate of the sensitivity.  
Average Starting 
Concentration 
5  103 CFU/mL 
Average Final 
Concentration 




Table 5, below, shows sensitivities for numerous organisms, all estimated by adding 
known concentrations of organisms to a sample of growth media and comparing against a 
baseline reading of the same growth media. It is important to note that these estimates are in 
a pure sample of growth media, since filtration will undoubtedly leave some debris behind 
causing signal noise in the nephelometer readings. Further, these estimates are based on a 
signal increase of about 25 mV over baseline nephelometer readings. 25 mV is chosen 
because a signal-increase of >25 mV is indicative of growth and is not likely noise from the 
detector. The curve of E. coli growth monitored via the nephelometer, Figure 13, makes this 
25mV cutoff more intuitive.  
 
Table 5.  Direct to nephelometer sensitivity estimates. 
Organism Sensitivity Estimate 
E. coli 106 CFU/mL 
C. albicans 105 CFU/mL 
S. pneumoniae 5106 CFU/mL 
E. faecalis 5106 CFU/mL 
S. aureus 5106 CFU/mL 
P. aeruginosa 5106 CFU/mL 
 
The curve in Figure 13 was generated by spiking a known concentration of E. coli 
into a cuvette containing growth media, and then repeatedly recording the scattering. Like the 
developed resazurin system, this nephelometry setup does not have real-time detection 
algorithms; however, a sample was taken from the cuvette at 355 minutes, which is the 
estimated time to reach 106 CFU/mL. The resulting concentration of 1.5x106 CFU/mL, and 
corresponding 20-25 mV signal increase over baseline, shows that experiments culturing E. 




Figure 13. Growth curve of E. coli. 
 
Curves were also generated for other organisms contained in Table 5. A sample of 
these other growth curves is shown in Figure 14. The concentration following a ~25mV 
signal increase for these organisms also fit well with the sensitivity estimates in Table 5. The 
growth curves in Figure 14 do not independently measure the sensitivity of the method, but 
rather verify the concentration required for a 25mV increase over baseline, previously 
estimated in Table 5. Further, these curves demonstrate additional noise that is not seen in the 
E. coli example. This added noise, likely due to the need to mix these samples before taking a 
measurement, shows a potential complication when filtration debris is introduced into the 
system. 
 
Starting concentration 100 CFU/mL 





Figure 14. Growth curves for selected organisms. 
 
 In order to observe the effect blood debris will have on the noise of the nephelometer 
measurements, an experiment was setup to add debris to the cuvette to introduce the noise. 
The experiment, described in Protocol 5, contains all steps from blood collection to 
positivity. Since it has already been shown that the transport media will sustain relevant 
microorganisms through digestion when in the absence of antibiotics, the bacteria are spiked 
into the sample blood following digestion. Spiking in this manner does not allow the 
organisms to grow before filtration, so it is possible to approximate the number of organisms 






Figure 15. Nephelometer growth curves from entire process. 
 
 
Fastidious Organism Growth 
This filtration system rinses nearly all blood components from the filter surface 
ensuring detection via light scattering is possible without high interference. This is extremely 
important for detection, but the growth of a few organisms is dependent upon components of 
blood. The most clinically relevant of these organisms is Haemophilus influenzae. 
Haemophilus influenzae is reliant on two growth factors found in blood: Component A and 
Component B. Since these factors were thought to be removed via filtration, the growth 
media was supplemented with a concentration of Component A and a concentration of 
Component E. Component E is a precursor to Component B, which can be converted to 
Component B through salvage pathways in numerous microorganisms, including 
Haemophilus influenzae. Supplementation using Component E was chosen over Component 
B, since Component B is unstable in solution, which would lead to an unacceptably short 
shelf life of any growth media. Figure 16, below, shows growth results in media 




Figure 16.  H. influenzae growth with varied concentrations of Component E and Component 
A. The red line indicates the growth rate when H. influenzae is in a 1:1 mixture of blood and 
growth media. This is the target growth rate. n=2 for each condition. 
 
The above results indicate that the Component E was not being converted to 
Component B as quickly as necessary and resulted in growth rates of greater than 100 
minutes per generation. Further, high concentrations of Component E, are known to inhibit 
the growth of Candida albicans, which is a clinically relevant infectious yeast.  
Since Component E supplementation did not lead to acceptable growth rates, a few 
other alternatives were explored. Table 6, below, describes the formulations tested in Figures 
17 and 18. Standard media is a basic growth media used in BACTEC systems, while the 





Table 6. Growth media formulation abbreviations used in Figures 16 and 17. 
Abbreviation Description 
SA Standard media 
Supplement F Media with Supplement F 
Conc1 CompA Nutrient rich media with added Component A 
CompE Added Component E 
CompB Added Component B 
 
Figure 17, below, shows the growth rates of Candida albicans in different growth 
medias. This plot clearly shows the inhibitory effect of Component E on C. albicans growth. 
The other growth media all produced similar growth rates, with the nutrient rich formulations 
slightly outperforming the standard, regardless of extra additions such as Supplement F or 
Component B. This plot also shows that the media additives, other than Component E, did 
not affect the growth rate of C. albicans. Media with added Component B or Supplement F 
had rates essentially equivalent to the plain high nutrient media with Component A. 
 




Tests using a Component B spike, as opposed to Component E, led to a 3-fold faster 
growth rate (n=3), p<0.05. Spiking with small amounts of blood led to growth rates twice as 
fast as Component E spiking (n=3) p<0.05. Interestingly, filtration appeared to leave behind 
enough Component B to allow reasonable Haemophilus growth. Figures 18 and 19 
summarize this data. Also of note, all of the growth work was carried out based on Protocol 
6, contained in the appendix. 
 
Figure 18. H. influenzae growth rates in standard media with different additives (n=3).  
 
 Within standard media containing supplement F, the bacteria grew three times faster 
than in media containing Component E (n=3), p<0.05. The difference in growth rate between 
bacteria growing in standard media supplemented with Supplement F and 0.1mL of whole 
blood was not statistically significant, p>0.05. The was no growth when only filter residue 
was added to the standard media. Generation times within standard media containing 0.01mL 
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of lysed blood were twice as long as those within standard media containing 0.01mL of 
whole blood (n=3), p<0.05.  
H. influenzae appeared to grow much more quickly in the nutrient rich media with 
added Component A, shown in Figure 19. Most notably, nutrient rich media supplemented 
with Component A allowed growth to occur with only filter residue, whereas standard media 
did not support such growth. As expected the bacteria grew quickest when Supplement F and 
Component B were supplemented, with both producing a 3-fold higher growth rate than 
media supplemented with Component E (n=3), p<0.05. The difference in growth rate when 
both standard and nutrient rich media contain Supplement F was insignificant. 
 










Since each detection mechanism is reliant on microorganism growth, it is important 
to show that a representative array of organisms can be cultured within the developed 
nutrient rich media. Following Protocol 7, generation times of multiple organisms were 
calculated, as shown in Table 7. The effect of agitation on the growth rate is important 
because some detection systems are more amenable to agitation than others. It should be 
noted that these calculated generation times in the developed nutrient rich media, fit nicely 
with those found in the literature and historically in BACTEC media. 
 
Table 7. Average generation time of organisms when incubated with or without agitation 
 
Workflow 
The final workflow for this system is similar to that stated in Protocol 5 and is 
showcased below in Figure 20.  
Generation time in minutes/generation 
E. coli   S. aureus   
Rotating 22.8±0.1 Rotating 30.0±1.1 
Stationary 24.8±0.1 Stationary 33.5±1.6 
E. faecalis P. aeruginosa 
Rotating 22.5±0.3 Rotating 35.3±0.8 
Stationary 24.1±0.4 Stationary 38.9±0.3 
C. albicans C. glabrata 
Rotating 71.9±0.3 Rotating 97.9±2.1 































The final transport buffer, composed of a number of proprietary ingredients, 
preserved organism viability for at least 4 hours in the absence of antibiotics. However, the 
presence of antibiotics greatly impacted organism viability in a few cases: e. 
faecalis/Antibiotic C and s. aureus/Antibiotic D, while others were protected against. Some 
of the protected cases include Component D reducing Antibiotic B and Component C 
protecting P. aeruginosa from Antibiotic A. Also able to survive a 4-hour transport window 
were the common combinations of: E. faecalis/Antibiotic E, E. coli/Antibiotic F, S. 
aureus/Antibiotic G, and P. aeruginosa/Antibiotic H. However, the inability to protect 
against all drug-microorganism combinations is a significant drawback that limits recovery 
when specific antibiotics are used. 
Figure 4, in the transport media development section, showed that, with the addition 
of 0.5 mL of protease and a 1-hour incubation at 35oC, sample filterability is maintained for 
at least 4 hours at the current composition. However, after 4 hours of transport, filterability 
becomes even more dependent on the patient, leading to filtration failure in some samples. 
This limits transport to a 4-hour window; however, blood culture transport times vary 
between hospitals, and while times can average as short as 40 minutes, other hospitals 
frequently take 24 hours to transport their blood culture samples to the lab.  
There are a number of potential causes for the decrease in filterability over an 
extended transport time. One potential is that once the blood cells are lysed, the cellular 
components and membrane debris may begin to aggregate. Another potential issue is 
coagulation. Although Component C is an anticoagulant and is present in a concentration 
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greater than what is typically used to preserve blood, it is possible that micro-coagulates 
develop and are just large enough to block pores on the filter membrane. SEM images were 
taken in an attempt to better understand the causes of filtration failure. Figure 10, filtration 
development section, shows an SEM image of the filter membrane with and without lysed 
and digested blood cells. Although it is unclear what specifically is caked on to the 
membrane, it is likely that the cellular membrane was poorly solubilized. Poor solubilization 
of the membrane, in conjunction with the release of proteins during cell lysis, could account 
for the debris seen in the SEM image. Further, extended transport time could allow for large 
membrane/protein aggregates to form before the addition of protease. Then since the protease 
is only added for 1 hour, it is possible that it does not have enough time to degrade structures 
deeper inside of the aggregate. 
 
Filtration Geometry 
 The simplistic nature of dead-end filtration led to its choice over tangential flow or 
other more complicated methods. Within dead-end filtration, different filter geometries were 
examined. Figure 6, showcases why the disc filter holder alignment was chosen over the 
rectangular preassembled vertical alignment. The vertical alignment allowed residual blood 
to remain on the back side of the filter, meaning that inhibitory factors or even antibiotics 
could remain in contact with the microorganisms of interest inhibiting their growth.  
 Further, the available filters in the vertical alignment are prefabricated and the 
housing layers are ultrasonically welded together, limiting the ability to change membrane 
materials. However, the horizontal disc filter holder is threaded, making it easy to 
interchange different membranes. The adjustability of the horizontal holder, coupled with the 
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ability to completely clear the backside separating all antibiotics and blood components, 
made it the clear choice of filtration geometry. 
 
Filter Membrane 
 Figure 7 shows that uncoated PCTE is the clear choice of filter membrane. Uncoated 
track-etched polycarbonate (PCTE) allowed for significantly faster flow rates when filtering 
lysed and digested blood. Only two PCTE membranes were tested, one containing a 
hydrophilic PVP coating and one with no coating. Of the non-track-etched membranes tested, 
PVDF performed best, however, there was no further exploration of its properties since the 
uncoated PCTE allowed for filtration at much lower pressure differentials and had double the 
flow rate. It was surprising that PES performed so poorly, since PES membranes are low 
protein binding and are commonly used for filtering microbiology fluids, such as culture 
media. Similarly, the CA membranes, which failed at a large pressure differential (-0.85 bar), 
are marketed specifically for filtration methods requiring maximum protein recovery in the 
filtrate. 
 The high failure rate of low protein binding membranes indicates that released 
proteins in the sample were not likely the leading cause of filtration failure. They still may 
have aggregated to clog portions of the filter, but proteins should not have bound to these 
filter materials. This supports the theory that membrane debris is the leading cause of fouling 
and pore blockage.  
Since different suppliers have their own proprietary manufacturing methods, it could 
be useful to see whether PES and CA filters from other suppliers also fail. It may also be 
beneficial to experiment with different coatings to change the surface properties of the filter 
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material to allow for greater flow rates under lower pressures, or to alleviate the need for 
such a long digestion process. Although it appears that improving membrane solubilization is 
the clearest path forward to improve filterability. 
 
Detection Method 
 Nephelometry is shown to have a much better sensitivity than resazurin and CO2 
sensing. Depending on the microorganism present, the signal change from nephelometry can 
be distinguished from noise at anywhere between 105 CFU/mL and 107 CFU/mL. This 
compares quite favorably to resazurin and CO2 sensing which have sensitivities 10–100-fold 
higher than nephelometry. Using a nephelometer to detect growth within the culture has a 
few drawbacks. Notably, the filtration process must remove nearly all of the digested blood 
components to avoid creating too much background noise. Further, the current setup requires 
agitation for detection purposes, since some microorganisms settle and do not scatter the 
incoming light. This adds an additional engineering challenge to create a complete system; 
however, as Protocol 5 and Figure 15 show, it is possible to implement an agitation 
mechanism by using a pump to pipette the microbial solution in order to agitate and promote 
gas exchange.  
 Figure 15 is also important because it follows the entire system workflow and 
demonstrates detection times achieved using a starting organism load between 10-100 CFU. 
This is important because it verifies a calculated comparison between traditional BACTEC 
time to detection and the time to detection of the new system. Table 8, below, shows the 
calculated comparison. Figure 15 showed that starting with ~30 total CFU of E. coli and S. 
aureus, gave TTDs of 7.2 hours and 10.6 hours respectively. The projection for E. coli (7.0 
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hours) fits very well with the TTD seen when testing the system. Although the projection for 
S. aureus (9.4 hours) is not quite as close, it is still within roughly 10% of the experimental 
TTD. Also, it is important to note that the testing setup involved eluting the bacteria from the 
filter in order to culture within a cuvette. This undoubtedly reduced the number of bacteria in 
culture, which could help explain why the theoretical times are slightly faster. 
 






Escherichia coli 11.0 7.0 
Enterococcus faecalis 11.2 7.1 
Staphylococcus aureus 14.0 9.4 
Pseudomonas aeruginosa 16.4 11.1 
Candida albicans 23.5 16.4 
Haemophilus influenzae 23.0 22.0 
Candida glabrata 47.2 24.0 
 
 Table 8 was constructed by simply stacking the TTD savings afforded by this system. 
The savings from volume reduction is strictly mathematical. A BACTEC bottle contains 
roughly 40 mL total volume, meaning that an initial load of 30 CFU begins at a concentration 
of 0.75 CFU/mL. In the devised system the volume in the cuvette is 2 mL (and can easily be 
reduced further), so an initial load of 30 CFU begins at a concentration of 15 CFU/mL 
(assuming all organisms are recovered in the cuvette). The other time savings is due to the 
increase in sensitivity of the nephelometer over the indirect CO2 sensing. For the BACTEC, 
the bacteria must proliferate to increase their concentration from 0.75 CFU/mL to the 
detection threshold which is on the order of 108 CFU/mL for bacteria such as E. coli. 
Detection via nephelometry is more sensitive, so that bacteria must reach a threshold around 
5x106 CFU/mL and yeasts must reach roughly 105 CFU/mL. In this system the organisms of 
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interest begin at a higher concentration and must reach a lower concentration than in previous 
systems. 
 The calculations to develop the projected TTDs of this system are based on two 
equations. The first is used to calculate the number of doublings needed to reach the 
detection threshold of the nephelometer: [𝑓𝑖𝑛𝑎𝑙] = [𝑖𝑛𝑖𝑡𝑖𝑎𝑙] × 2𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛𝑠. Once 
the number of generations required is calculated, simply multiply by the generation time to 
calculate the time to detection: 𝑇𝑇𝐷 = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛𝑠 × 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛 𝑡𝑖𝑚𝑒. In 
projecting the system TTDs, sensitivity estimates, such as those in Table 5, were used, but 
had roughly 40% added to them to help account for the higher threshold when noise is 
present from the filter debris. The generation time in the presence of filter residue was used 
for H. influenzae, and times from Table 7 were used for the rest of the organisms. 
 The projections in Table 7 are extremely impressive. The largest reduction in TTD 
occurs for organisms with slower growth rates, such as the Candidas. C. glabrata has a 
projected time savings of nearly an entire day, although this organism is known to settle out 
of suspension, so it would be interesting to test this organism according to Protocol 5 to see if 
the projections still hold. Also of note, despite the H. influenzae growth rate being 
suboptimal, it still is projected to perform on par with the historical BACTEC standard 
thanks to the volume reduction. 
 
Fastidious Growth 
 Since the filtration system removes nearly all blood components from the filter 
surface, it is necessary to ensure organisms that require certain blood components are still 
able to grow. Haemophilus influenzae is the most common of these organisms and is 
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dependent on Component A and Component B, both found in blood. Figure 16 shows that 
using the Component B precursor, Component E, is not effective for the culture of 
Haemophilus. This was unexpected since many commercial blood culture systems are 
supplemented with Component E. However, these systems all maintain the presence of whole 
blood throughout the culture process, so it is likely that the added Component E is having 
little effect on Haemophilus growth in such systems.  
 Supplementation with Supplement F performed extremely well, as expected, but the 
H. influenzae growth in the presence of just the filter residue was extremely surprising. This 
is even more surprising given that no growth at all occurred in the nutrient rich Component A 
media when it was not supplemented, shown as column “blank” in Figure 19. This implies 
that enough Component B, or precursors allowing for the synthesis of Component B, remains 
on the filter to support growth of H. influenzae at a reduced rate. The residual Component B 
is likely due to protein-bound Component B not being able to pass through the filter pores, 
which supports protein aggregation as a cause of filter clogging. H. influenza is rarely the 
causative agent in sepsis, so this reduced rate may be acceptable given overall improvements 
given by filtration. However, it is worrisome to rely on the filter to retain needed nutrients, 
and would likely be better to add fresh Component B to a growth media stock as needed. 
 
General Growth 
 The growth rates of all non-fastidious organisms in the absence of antibiotics should 
be equal to or better than the rates in a traditional blood culture system. This is because the 
basis of the growth media is a high performing automated culture media; however, for this 
system certain nutrients could be increased without worry of interfering with the detection 
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mechanism. Further, the removal of all inhibitory blood components, while supplying those 
that are necessary, will likely increase the growth rate of microorganisms that are inhibited 
by such components. 
 
Workflow 
 The workflow for this device is much more involved than the traditional blood culture 
workflow. In its current form the workflow presents too many opportunities for 
contamination or user error. However, the principles applied in this workflow can be 
implemented in a closed device. Future iterations should combine and automate steps to 
ensure a closed system with minimal likelihood of contamination or room for user error. One 
possible embodiment is an inclusive filtration/detection concept.  In this concept, the steps 
following the lysis and digestion of the sample are all contained within one simple device. 
Media can be drawn in behind the digested blood and then filtered and transferred to a 
cuvette, without the possibility of contamination or loss of organism. 
 This concept describes a simple closed system from the point of blood digestion 
onward, but transport is also an issue. A potential solution for the issues presented by 
transport is to have a reusable sample transport system which integrates a collection device 
with the filtration and detection concept. Such a system could be comprised of a portable 
incubator containing filtration consumables. When a sample is added, a timer on the 
incubator would start, and following an hour digestion period, the filtration system would be 
activated, allowing automated control of the filtration steps. 
Having a reusable device that would allow immediate addition of protease and start of 
incubation would result in a massive time savings. Instead of up to 24 hours of wasted time 
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during transport, a sample could be digested and filtered within the first hour of transport, 
leaving the remaining transport time as additional growth time. This savings of previously 
lost time, would allow many samples to arrive at the lab immediately prepared for 
identification and antibiotic susceptibility testing. This would amount to a TTD reduction of 
the transport time for every sample, in addition to the savings already afforded by decreased 




The designed device allows for the collection, transport, filtration, incubation/growth, 
and detection of infectious microorganisms contained in blood samples of potentially septic 
patients. Within a 4-hour transport window and in the absence of Antibiotic D and Antibiotic 
C, this device significantly outperforms the current blood culture standard, reducing time to 
detection by hours across organisms. However, these are relatively stringent constraints. The 
transport time constraint cannot be met by all hospitals, which would undoubtedly lead to 
filtration failures causing samples to be inconclusive, further delaying identification and 
antimicrobial susceptibility results. Also, the transport media struggles to protect against 
Antibiotic D or Antibiotic C, so patients receiving these antibiotics would be at an increased 
risk of receiving a false negative. 
 There are a number of ways to address these deficiencies of the current device. To 
escape the issues of extended transport, samples could be placed into a transport container, 
which performs multiple functions to prepare and preserve the sample. Such a transport 
container would also alleviate some issues with antibiotics as well. By filtering within 1 hour 
the media would only have to protect the microorganisms for a fraction of the time and 
certain antibiotic-microbial combinations that were unrecoverable at 4 hours would once 
again become recoverable. Such a method would significantly decrease time to detection, 
while also improving recovery.  
Another solution, which removes the drawbacks of transport, would be to move 
towards a near-patient model where the blood sample is filtered without a dependence on 
time and temperature. The workflow of such a system would be more straightforward than a 
reusable carrier and would allow immediate separation of the microorganism from any 
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inhibitory factors and antibiotics; however, this would require a rework of the transport 
media and digestion procedure. Near-patient filtration would be a difficult task, however, the 
foundation of the current filtration method and in place downstream processes, could make 







Protocol 1: General Fresh Blood Filtration (Vertical Filter Method) 
1. Draw 10 mL of blood from donor into a 10-mL syringe. 
2. Inoculate fresh blood into bottle of transport media. 
3. Allow bottle to sit on benchtop for desired “transport time”. 
4. Following transport, add 200 units of protease A. 
5. Place sample bottle in a rocking incubator at 35oC for 1 hour. 
6. After incubation, remove bottle from incubator, de-cap 
7. Attach vertical filter to peristaltic pump and lower filter tip into the sample. 
8. Turn on the pump and record the time for the sample to completely filter. 
 
Protocol 2: Antibiotic-Susceptible Microorganism Transport Media Testing 
1. Prepare a solution of the antibiotic of interest. 
2. Prepare a 1.0 McFarland suspension of organism and dilute to desired concentration. 
3. Take a sample from this suspension and plate to ensure there is no contamination and 
the sample concentration is accurate. 
4. Add antibiotic to transport media, in a concentration equal to expected peak serum 
level. 
5. Add desired quantity of the microorganism dilution to the sample. 
6. Sit on benchtop for 4 hours and then add 200 units of protease A and incubate at 35oC 
for 1 hour. 
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7. Remove from incubator and sample from each bottle, making necessary dilutions 
before inoculating several plates. 
8. Once organism has grown on the initial and final plates, calculate the recovery. 
 
Protocol 3: Filter Membrane Characterization 
1. Add 10 mL fresh blood sample to transport media. 
2. Immediately add 200 units of protease A and incubate at 35oC for 1 hour. 
3. Prepare filtration setup by attaching 47-mm disk filter membrane to manifold filter 
holder. 
4. Close manifold. 
5. Attach vacuum pump to manifold and adjust vacuum pressure to desired amount. 
6. After incubation, pour sample onto open filter holder. 
7. Open the manifold and start timer. 
8. Once sample has been cleared from filter surface, stop timer. 
9. Repeat using a new filter membrane and new disposable filter holder. 
 
Protocol 4: 25 mm Filter Holder Characterization 
1. Add 10mL fresh blood sample to transport media. 
2. Immediately add 200 units of protease A and incubate at 35oC for 1 hour. 
3. Prepare filter holder by placing hydrophobic PCTE filter membrane inside filter 
holder. 
4. Attach filter to vacuum pump and set vacuum pressure to -0.90 bar. 
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5. After incubation, use a 30-mL syringe to remove entire sample from transport media 
bottle. 
6. Attach syringe to filter holder. 
7. Turn on vacuum and begin timer. 
8. Stop timer once entire sample has filtered. 
 
Protocol 5: Nephelometry Detection, Sample Collection through Positivity 
1. Collect 10 mL of fresh blood from donor and add directly to transport media. 
2. Allow transport media to sit on benchtop for 1 hour. 
3. Add 200 units of protease A and incubate at 35oC for 1 hour. 
4. Prepare 25 mm filter holder by inserting hydrophobic PCTE membrane and 
connecting to vacuum pump.  
5. After incubation, spike ~30 CFU into lysed and digested blood sample. 
a. ~30 CFU obtained by creating 1.0 McFarland and diluting 106 times and then 
adding 0.1 mL of the 106 dilution. 
6. Remove entire sample (~22 mL) from bottle using a 30-mL syringe. 
7. Connect syringe to filter and turn on vacuum pump to -0.90 bar. 
8. Once entire sample has filtered, disconnect 30 mL syringe and connect 10 mL syringe 
filled with growth media. 
9. Allow entire syringe of growth media to rinse through filter. 
10. Disconnect filter from vacuum pump and connect 5 mL syringe containing growth 
media to the filtrate side of the filter. 
a. Attach opposite side bacteria captured on. 
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11. Backflow 2 mL from the filter and collect in polystyrene cuvette. 
12. Place cuvette inside a nephelometer within an incubator. 
13. Connect a syringe pump, programmed to aspirate and dispense 0.5 mL of sample. 
a. This mixing keeps the particles from settling. 
14. Allow to incubate at 35oC until change in curve indicates positivity. 
 
Protocol 6: Growth Media Studies 
1. Add 5 mL of base media to 15 mL conical tube. 
2. Add any additional supplements to desired concentration. 
a. i.e. Component E, Component B, Supplement F, whole blood, lysed blood, 
filter residue. 
i. Lysed blood acquired by following Protocol 1 through step 5. 
ii. Filter residue acquired by following Protocol 5 through step 11, but 
collecting eluate in with growth media instead of in cuvette. 
3. Spike known concentration of H. influenzae or C. albicans. 
4. Place on rotisserie rotator inside of incubator set to 35oC. 
5. After ~16 hours remove from incubator and dilute and plate. 
a. Make 10x serial dilutions by adding 0.5 mL of preceding dilution to 4.5 mL of 
sterile saline. 
b. Plate 0.1 mL of each dilution on appropriate agar plate. 





Protocol 7: Organism Growth Testing With or Without Agitation 
1. Prepare McFarland standard for each organism to be tested. 
2. Dilute the standards for bacteria 106 times and those for yeasts 104 times. Plate final 
dilutions to ensure concentrations are known and there is no contamination. 
3. Add 16 mL of nutrient rich media to 50 mL conical tube for each organism to be 
tested. 
4. Add 2 mL of the diluted organism to a tube; repeat for each organism in a different 
tube. 
5. Vortex to mix. 
6. Take six 1-mL samples from each 50-mL tube and dispense into 1.5-mL tubes. 
Generate six 1.5-mL samples for each organism. 
7. Place three samples from each organism into a rotating mixer (~25 rpm). 
8. Place other three samples from each organism on stationary tray. 
9. Place mixer and tray inside incubator at 35oC. 
10. Based on known generation times of the organism calculate length of time to ~106 
CFU/mL for bacteria and 105 CFU/mL for yeasts. 
11. Use these calculated times to remove samples at the proper time. 
12. Dilute samples and inoculate plates. 
13. Count plates and calculate final concentration 
14. From the final concentration and initial concentration calculate the estimated 
generation time. 
a. [𝑓𝑖𝑛𝑎𝑙] = [𝑖𝑛𝑖𝑡𝑖𝑎𝑙] × 2𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛𝑠 
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